Does GLICLAZIDE Cause Decreased appetite? 141 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 141 reports of Decreased appetite have been filed in association with GLICLAZIDE. This represents 2.4% of all adverse event reports for GLICLAZIDE.
141
Reports of Decreased appetite with GLICLAZIDE
2.4%
of all GLICLAZIDE reports
15
Deaths
64
Hospitalizations
How Dangerous Is Decreased appetite From GLICLAZIDE?
Of the 141 reports, 15 (10.6%) resulted in death, 64 (45.4%) required hospitalization, and 6 (4.3%) were considered life-threatening.
Is Decreased appetite Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for GLICLAZIDE. However, 141 reports have been filed with the FAERS database.
What Other Side Effects Does GLICLAZIDE Cause?
Hypoglycaemia (756)
Nausea (596)
Acute kidney injury (553)
Drug ineffective (507)
Fall (415)
Dyspnoea (400)
Vomiting (385)
Lactic acidosis (373)
Malaise (360)
Hypertension (351)
What Other Drugs Cause Decreased appetite?
ADALIMUMAB (6,135)
LENALIDOMIDE (5,103)
SEMAGLUTIDE (4,317)
METHOTREXATE (4,229)
CABOZANTINIB S-MALATE (4,076)
APREMILAST (3,442)
RITUXIMAB (3,438)
PALBOCICLIB (3,400)
PREDNISONE (3,390)
LENVATINIB (3,257)
Which GLICLAZIDE Alternatives Have Lower Decreased appetite Risk?
GLICLAZIDE vs GLIMEPIRIDE
GLICLAZIDE vs GLIMEPIRIDE\ROSIGLITAZONE
GLICLAZIDE vs GLIPIZIDE
GLICLAZIDE vs GLIVEC
GLICLAZIDE vs GLOFITAMAB